AbCellera BiologicsABCL
那斯達克 · USD
5.53
+0.09
(+1.65%)
收盤 06/19 03:59 (UTC+8)
盤後
5.55
+0.02
(+0.36%)
06/19 03:59 (UTC+8)
AbCellera BiologicsABCL
5.53
+0.09
(+1.65%)
財務數據
損益表
- 0.09
- 0.10
- 0.07
- 0.07
- 0.05
- 0.04
- 0.17
- 0.09
- 0.45
- 0.08
- 39.12
- 8.44
- -26.43
- -11.16
- -22.38
- -16.14
- 303.42
- -47.59
- 400.87
- -81.46
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 8,315 | 44,853 | 8,955 | 17,085 | 4,235 | 5,050 | 6,506 | 7,323 | 9,954 | 9,179 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 8,315 | 44,853 | 8,955 | 17,085 | 4,235 | 5,050 | 6,506 | 7,323 | 9,954 | 9,179 |
營業費用 | 65,834 | 73,435 | 85,230 | 66,671 | 66,895 | 77,805 | - | 100,777 | - | 75,232 |
研發費用 | 46,662 | 50,093 | 55,025 | 39,215 | 42,496 | 46,076 | 40,969 | 40,927 | 39,287 | 48,622 |
推銷及管理費用 | 12,334 | 17,219 | 24,958 | 21,986 | 19,068 | 19,164 | 22,281 | 23,328 | 20,717 | 19,074 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 6,838 | 6,123 | 5,247 | 5,470 | 5,331 | 12,565 | 36,919 | 36,522 | 4,844 | 7,536 |
營業利益 | -53,180 | -25,266 | -76,275 | -49,586 | -62,660 | -72,755 | -93,663 | -93,454 | -54,894 | -66,053 |
其他收入及費用 | 7,982 | 9,083 | 7,507 | 13,242 | 9,676 | 25,926 | 31,031 | 45,267 | 12,147 | 17,451 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -49,537 | -19,499 | -68,768 | -36,344 | -52,984 | -46,829 | -62,632 | -48,187 | -42,747 | -48,602 |
所得稅 | -6,372 | -10,554 | -11,649 | -1,617 | -7,363 | -12,619 | -11,525 | -11,257 | -2,137 | -1,452 |
稅後純益 | -43,165 | -8,945 | -57,119 | -34,727 | -45,621 | -34,210 | -51,107 | -36,930 | -40,610 | -47,150 |
基本每股稅後盈餘(元) | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.11 | -0.17 | -0.13 | -0.14 | - |
稀釋每股稅後盈餘(元) | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.11 | -0.18 | -0.12 | -0.14 | -0.17 |
基本平均股數(千股) | 303074.00 | 299753.00 | 298875.00 | 298508.00 | 297692.00 | 295519.00 | 294851.00 | 294217.00 | 292723.00 | - |
稀釋平均股數(千股) | 303074.00 | 299753.00 | 298875.00 | 298508.00 | 297692.00 | 295519.00 | 294851.00 | 294217.00 | 292723.00 | - |
還原基本每股稅後盈餘(元) | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.11 | -0.17 | -0.13 | -0.14 | - |
還原稀釋每股稅後盈餘(元) | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.11 | -0.18 | -0.12 | -0.14 | -0.17 |
還原基本平均股數(千股) | 303,074 | 299,753 | 298,875 | 298,508 | 297,692 | 295,519 | 294,851 | 294,217 | 292,723 | - |
還原稀釋平均股數(千股) | 303,074 | 299,753 | 298,875 | 298,508 | 297,692 | 295,519 | 294,851 | 294,217 | 292,723 | - |
EBITDA(千元) | -40,882 | -11,579 | -61,532 | -29,284 | -46,379 | -32,929 | -24,337 | -10,150 | -35,981 | -39,493 |